Eco R1 Capital, LLC Erytech Pharma S.A. Transaction History

Eco R1 Capital, LLC

  • $2.31 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019
SELL
$5.54 - $9.23 $385,412 - $642,121
-69,569 Closed
0 $0
Q3 2018

Nov 14, 2018
SELL
$8.57 - $11.41 $723,265 - $962,946
-84,395 Reduced 54.81%
69,569 $590,000
Q2 2018

Aug 14, 2018
BUY
$11.17 - $21.41 $1.72 Million - $3.3 Million
153,964 New
153,964 $1.73 Million

About Erytech Pharma S.A.

ERYP Quotes by TradingView
  • Ticker ERYP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,018,600
  • Market Cap $16.8M
  • Description
  • ERYTECH Pharma S.A., a clinical-stage biopharmaceutical company, develops red blood cell-based therapeutics for cancer and orphan diseases in France and the United States. Its lead product candidate is eryaspase, which is in Phase 3 clinical development for the treatment of second-line pancreatic cancer, and in Phase 2 stage for the treatment of...
More about ERYP
Track This Portfolio

Track Eco R1 Capital, LLC Portfolio

Follow Eco R1 Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eco R1 Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email